|
|
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma
Laurent Garderet
,
Simona Iacobelli
,
Linda Koster
,
Hartmut Goldschmidt
,
Jan-Erik Johansson
et al.
Article dans une revue
hal-01975406v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
Maxime Jullien
,
Benoit Tessoulin
,
Hervé Ghesquières
,
Lucie Oberic
,
Franck Morschhauser
et al.
Article dans une revue
inserm-03540506v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA
D. Ghez
,
C. Fortpied
,
N. Mounier
,
P. Carde
,
A. Perrot
et al.
Haematologica, 2016, 101 (5), pp.50
Article dans une revue
hal-03605056v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
Rene-Olivier Casasnovas
,
Reda Bouabdallah
,
Pauline Brice
,
Julien Lazarovici
,
Hervé Ghesquieres
et al.
Lancet Oncology, 2019
Article dans une revue
hal-01996114v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA
Lining Wang
,
Emmanuel Raffoux
,
Xavier Thomas
,
Ibrahim Yakoub-Agha
,
Jean-Henri Bouhris
et al.
Article dans une revue
hal-01557470v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
Cédric Rossi
,
Julia Gilhodes
,
Marie Maerevoet
,
Charles Herbaux
,
Franck Morschhauser
et al.
Article dans une revue
hal-02050402v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study
Amira Marouf
,
Anne Segolene Cottereau
,
Salim Kanoun
,
Paul Deschamps
,
Michel Meignan
et al.
Article dans une revue
hal-03628340v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.
Xavier Thomas
,
Stéphane de Botton
,
Sylvie Chevret
,
Denis Caillot
,
Emmanuel Raffoux
et al.
Article dans une revue
hal-01557436v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial
Benoit Tessoulin
,
David Chiron
,
Catherine Thieblemont
,
Lucie Oberic
,
Kamal Bouadballah
et al.
Article dans une revue
hal-03203334v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents
M Duchmann
,
B Braun
,
J.B. Micol
,
P Platzbecker
,
P. Park
et al.
Article dans une revue
hal-01655936v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study
Domitille Costes-Tertrais
,
Thomas Hueso
,
Thomas Gastinne
,
Catherine Thieblemont
,
Lucie Oberic
et al.
Article dans une revue
hal-03608256v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study
Rene-Olivier Casasnovas
,
Reda Bouabdallah
,
Pauline Brice
,
Julien Lazarovici
,
Hervé Ghesquieres
et al.
Article dans une revue
hal-02263798v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|